U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07036809) titled 'Assessment of Antithrombin III, Protein C, Protein S and D-dimer in Acute Leukemia' on June 17.
Brief Summary: The goal of this observational study is to evaluate the levels of Antithrombin III, Protein C, Protein S, and D-dimer in patients with Acute Leukemia (Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML)). The main questions it aims to answer are:
What are the levels of Antithrombin III, Protein C, Protein S, and D-dimer in patients with Acute Lymphoblastic Leukemia? What are the levels of Antithrombin III, Protein C, Protein S, and D-dimer in patients with Acute Myeloid Leukemia? Researchers will compare pa...